| Entry |
|
|---|
| Name |
Risedronate sodium monohydrate |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C7H10NO7P2. Na. H2O
|
|---|
| Exact mass |
322.9936
|
|---|
| Mol weight |
323.1094
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (DG00786): | D00942<US> D03234<JP/US> D11570<US> |
|
|---|
| Efficacy |
Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor |
|---|
| Disease |
Osteoporosis [DS: H01593] Glucocorticoid-induced osteoporosis [DS: H01709] Paget's disease [DS: H00437] |
|---|
| Comment |
Bisphosphonate
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00900 | Terpenoid backbone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Alkyl/Aryl transferases
FDPS
D11570 Risedronate sodium monohydrate <US>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 Z Na 22.0420 -18.5799 #+
2 C1d C 17.9448 -17.2377
3 P1b P 19.1457 -17.8735
4 P1b P 16.7439 -17.8735
5 C1b C 17.9448 -15.8956
6 C8y C 19.1457 -15.1892
7 C8x C 20.2760 -15.8956
8 N5x N 21.4769 -15.1892
9 C8x C 21.4769 -13.7763
10 C8x C 20.2760 -13.0699
11 C8x C 19.1457 -13.7763
12 O1c O 15.5430 -17.2377
13 O1c O 16.7439 -19.2863
14 O1c O 15.1898 -18.8625
15 O1c O 20.2760 -17.2377
16 O1c O 19.1457 -19.2863
17 O1c O 20.2760 -18.5799 #-
18 O1a O 17.9448 -18.6506
19 O0 O 23.0300 -20.0200
BOND 17
1 2 3 1
2 2 4 1
3 2 5 1
4 5 6 1
5 6 7 2
6 7 8 1
7 8 9 2
8 9 10 1
9 10 11 2
10 6 11 1
11 4 12 2
12 4 13 1
13 4 14 1
14 3 15 2
15 3 16 1
16 3 17 1
17 2 18 1
|
|---|
